All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2005-000813-36 | A phase II, multicentre, single-arm, open-label study of subcutaneous homoharringtonine (HHT) alone in patients with accelerated phase chronic myeloid leukemia (CML) who are refractory to, or have rel... | 2007-10-01 | due-trials |
Reported results | 2005-000814-11 | A phase II, multicentre, open-label, single arm, extension study of maintenance treatment with subcutaneous homoharringtonine (HHT) as a single agent in patients with chronic myeloid leukemia (CML) wh... | 2007-10-01 | due-trials |
Reported results | 2006-000176-32 | A Phase II Open-Label Study of the Subcutaneous Administration of Homoharringtonine (CGX-635) in the Treatment of Patients with Chronic Myeloid Leukemia (CML) with the T315I BCR-ABL Gene Mutation | 2013-08-05 | due-trials |
Ongoing | 2006-004517-17 | A Phase II Open-Label Study of the Subcutaneous Administration of Homoharringtonine (CGX-635) in the Treatment of Refractory or Relapsed Acute Myeloid Leukemia (AML) | not-yet-due | |
Reported results | 2007-001286-15 | A Phase II Open-Label Study of the Subcutaneous Administration of Homoharringtonine (CGX-635) in the Treatment of Patients with Chronic Myeloid Leukemia (CML) who have failed or are intolerant to tyro... | 2013-06-27 | due-trials |